{"transactions":[{"id":1800566,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options","published_at":"2023-08-21T18:00:16.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17,2023."}],"balance_after":50000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-029733","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340428/000149315223029733/ownership.xml","form_type":"4"}},{"id":1860239,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:28.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-020795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020795/ownership.xml","form_type":"4"}},{"id":1924741,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-04-05T20:28:15.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) 250,000 on the date of grant; (ii) 250,000 on the first anniversary of the date of grant; and (iii) 250,000 on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":750000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001493152-23-011040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223011040/ownership.xml","form_type":"4"}},{"id":2541436,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:24.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-025601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025601/ownership.xml","form_type":"4"}},{"id":2742872,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":96475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 250,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":96475,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":96475},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742871,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742870,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742869,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":38590,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Merger in exchange for a stock option to acquire 100,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":38590,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":38590},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742868,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Common Stock","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":96475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 250,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."}],"balance_after":96475,"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}}]}